Chlamydial Manipulation of Host Apoptosis
Chlamydial Manipulation of Host Apoptosis
批准号:
7031922
负责人:
GUANGMING ZHONG
金额:
$32.85万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-02-15 至 2011-01-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): --Mechanisms of Chlamydial Manipulation of Host Cell Apoptosis-- Chlamydial infection in humans imposes a major health problem in both developing and developed nations. Urogenital tract infection with C. trachomatis species is a leading cause of sexually transmitted bacterial diseases and is also linked to certain type of cervical carcinoma while respiratory infection with C. pneumoniae species is associated with atherosclerosis, a major vascular condition for cardio-cerebral fatality. Although the species C. psittaci is primarily an animal pathogen, humans are also susceptible to C. psittaci infection, developing life-threatening pneumonia. Since humans can acquire infection via aerosolized animal feces that are contaminated with C. psittaci organisms, CDC has once listed C. psittaci as a category B agent for biodefense. These chlamydia-induced or -associated pathologies are largely due to Chlamydial ability to either productively replicate or to achieve a long-term persistence within a cytoplasmic vacuole of eukaryotic cells, which are aided by the Chlamydial unique intracellular biphasic life cycle and the Chlamydial ability to evade host defense. The current proposal is designed to understand how chlamydia evades a very important host defense effector mechanism-apoptosis. We have previously demonstrated that chlamydia possesses a potent anti-apoptotic activity, which may contribute to the Chlamydial ability to survive in the infected hosts for long periods of time. By identifying the molecule(s) responsible for the Chlamydial anti-apoptotic activity and understanding how the anti-apoptotic molecules work as proposed in the current project, we may be able to develop reagents/approaches for blocking the Chlamydial anti-apoptotic activity and preventing chlamydia-induced pathologies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Chlamydia pathogenesis
-
批准号:10665396
-
项目类别:
-
资助金额:$57.07万
-
财政年份:2022
-
负责人:GUANGMING ZHONG
-
依托单位:
Graduate Research in Immunology Program (GRIP): To train graduate students for successful careers in academia, industry and government
-
批准号:10186454
-
项目类别:
-
资助金额:$11.13万
-
财政年份:2018
-
负责人:GUANGMING ZHONG
-
依托单位:
Graduate Research in Immunology Program (GRIP): To train graduate students for successful careers in academia, industry and government
-
批准号:10410482
-
项目类别:
-
资助金额:$13.14万
-
财政年份:2018
-
负责人:GUANGMING ZHONG
-
依托单位:
Graduate Research in Immunology Program (GRIP): To train graduate students for successful careers in academia, industry and government
-
批准号:9757595
-
项目类别:
-
资助金额:$11.11万
-
财政年份:2018
-
负责人:GUANGMING ZHONG
-
依托单位:
Chlamydial Manipulation of Host Apoptosis
-
批准号:7559682
-
项目类别:
-
资助金额:$31.29万
-
财政年份:2006
-
负责人:GUANGMING ZHONG
-
依托单位:
Chlamydial Manipulation of Host Apoptosis
-
批准号:7760842
-
项目类别:
-
资助金额:$30.98万
-
财政年份:2006
-
负责人:GUANGMING ZHONG
-
依托单位:
Chlamydial Manipulation of Host Cell Apoptosis
-
批准号:7178453
-
项目类别:
-
资助金额:$31.9万
-
财政年份:2006
-
负责人:GUANGMING ZHONG
-
依托单位:
Chlamydial Manipulation of Host Apoptosis
-
批准号:7339909
-
项目类别:
-
资助金额:$31.29万
-
财政年份:2006
-
负责人:GUANGMING ZHONG
-
依托单位:
Chlamydia trachomatis proteomics
-
批准号:7337131
-
项目类别:
-
资助金额:$33.95万
-
财政年份:2005
-
负责人:GUANGMING ZHONG
-
依托单位:
Chlamydia trachomatis proteomics
-
批准号:8423042
-
项目类别:
-
资助金额:$34.9万
-
财政年份:2005
-
负责人:GUANGMING ZHONG
-
依托单位:
Chlamydia trachomatis proteomics
-
批准号:7538377
-
项目类别:
-
资助金额:$33.95万
-
财政年份:2005
-
负责人:GUANGMING ZHONG
-
依托单位:
Chlamydia trachomatis proteomics
-
批准号:8213426
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2005
-
负责人:GUANGMING ZHONG
-
依托单位:
Chlamydia trachomatis proteomics
-
批准号:7152929
-
项目类别:
-
资助金额:$34.61万
-
财政年份:2005
-
负责人:GUANGMING ZHONG
-
依托单位:
Chlamydia trachomatis proteomics
-
批准号:7037624
-
项目类别:
-
资助金额:$35.64万
-
财政年份:2005
-
负责人:GUANGMING ZHONG
-
依托单位:
Chlamydia trachomatis proteomics
-
批准号:8057006
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2005
-
负责人:GUANGMING ZHONG
-
依托单位:
Chlamydia trachomatis proteomics
-
批准号:8602787
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2005
-
负责人:GUANGMING ZHONG
-
依托单位:
Chlamydia trachomatis proteomics
-
批准号:6906307
-
项目类别:
-
资助金额:$31.03万
-
财政年份:2005
-
负责人:GUANGMING ZHONG
-
依托单位:
Chlamydial Manipulation of Host Apoptosis
-
批准号:6828399
-
项目类别:
-
资助金额:$32.85万
-
财政年份:2004
-
负责人:GUANGMING ZHONG
-
依托单位:
Novel Chlamydia Vaccine Candidates
-
批准号:6866201
-
项目类别:
-
资助金额:$20.57万
-
财政年份:2004
-
负责人:GUANGMING ZHONG
-
依托单位:
Exacerbation of Atherosclerosis
-
批准号:6750053
-
项目类别:
-
资助金额:$25.29万
-
财政年份:2001
-
负责人:GUANGMING ZHONG
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
-
批准号:31970691
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:张胜萍
-
依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
-
批准号:31900527
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:孙磊
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
姜黄素与TRAIL的协同抗肿瘤机制研究
-
批准号:31101223
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2011
-
负责人:曹林
-
依托单位:
转凝蛋白通过线粒体凋亡途径致足细胞凋亡的机制研究
-
批准号:81100502
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:管娜
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位: